A detailed history of Wrapmanager Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Wrapmanager Inc holds 11,650 shares of ABBV stock, worth $1.95 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
11,650
Previous 11,666 0.14%
Holding current value
$1.95 Million
Previous $1.81 Million 17.38%
% of portfolio
0.6%
Previous 0.53%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$159.82 - $182.1 $2,557 - $2,913
-16 Reduced 0.14%
11,650 $2.12 Million
Q4 2023

Feb 07, 2024

BUY
$137.6 - $154.97 $45,545 - $51,295
331 Added 2.92%
11,666 $1.81 Million
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $34,065 - $39,435
255 Added 2.3%
11,335 $1.69 Million
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $180,876 - $225,088
-1,365 Reduced 10.97%
11,080 $1.49 Million
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $1,446 - $1,665
10 Added 0.08%
12,445 $1.98 Million
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $60,026 - $71,987
434 Added 3.62%
12,435 $2.01 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $8,589 - $9,851
-64 Reduced 0.53%
12,001 $1.61 Million
Q2 2022

Aug 05, 2022

SELL
$137.62 - $174.96 $396,345 - $503,884
-2,880 Reduced 19.27%
12,065 $1.85 Million
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $276,366 - $342,892
-2,094 Reduced 12.29%
14,945 $2.42 Million
Q4 2021

Feb 07, 2022

SELL
$107.43 - $135.93 $14,825 - $18,758
-138 Reduced 0.8%
17,039 $2.31 Million
Q3 2021

Nov 10, 2021

SELL
$106.4 - $120.78 $41,176 - $46,741
-387 Reduced 2.2%
17,177 $1.85 Million
Q2 2021

Aug 04, 2021

BUY
$105.21 - $117.21 $29,564 - $32,936
281 Added 1.63%
17,564 $1.98 Million
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $227,208 - $250,129
-2,221 Reduced 11.39%
17,283 $1.87 Million
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $140,294 - $189,411
-1,743 Reduced 8.2%
19,504 $2.09 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $134,620 - $158,000
-1,567 Reduced 6.87%
21,247 $1.86 Million
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $44,535 - $59,595
607 Added 2.73%
22,814 $2.24 Million
Q1 2020

May 08, 2020

BUY
$64.5 - $97.79 $322,629 - $489,145
5,002 Added 29.07%
22,207 $1.69 Million
Q4 2019

Feb 11, 2020

SELL
$72.13 - $90.25 $254,618 - $318,582
-3,530 Reduced 17.02%
17,205 $1.52 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $106,877 - $128,496
1,697 Added 8.91%
20,735 $1.57 Million
Q2 2019

Jul 31, 2019

SELL
$65.7 - $83.98 $33,507 - $42,829
-510 Reduced 2.61%
19,038 $1.38 Million
Q1 2019

May 06, 2019

BUY
$77.14 - $90.79 $214,912 - $252,940
2,786 Added 16.62%
19,548 $1.58 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $667,719 - $823,477
8,577 Added 104.79%
16,762 $1.55 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $243,791 - $271,019
2,742 Added 50.38%
8,185 $774,000
Q2 2018

Aug 03, 2018

SELL
$89.78 - $106.23 $108,274 - $128,113
-1,206 Reduced 18.14%
5,443 $504,000
Q1 2018

May 03, 2018

SELL
$92.01 - $123.21 $829,838 - $1.11 Million
-9,019 Reduced 57.56%
6,649 $629,000
Q4 2017

Feb 02, 2018

SELL
$89.56 - $98.21 $1.02 Million - $1.12 Million
-11,407 Reduced 42.13%
15,668 $1.52 Million
Q3 2017

Nov 03, 2017

BUY
$69.85 - $89.22 $1.89 Million - $2.42 Million
27,075
27,075 $2.41 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wrapmanager Inc Portfolio

Follow Wrapmanager Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.